# TG Therapeutics, Inc. (TGTX): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for TG Therapeutics, Inc. (TGTX) is 48/100, ranked against 24,000+ stocks in 35 markets (Quality 67, Value 21, Momentum 53, each scored against its sector).

- StockRank: 48/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 67, Value 21, Momentum 53: each a 0-100 percentile within Healthcare.
- Position: #14,030 overall, #1,255 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 54.17 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors sold USD 275K.
- Buybacks, last 180 days: the company bought back USD 119.1M on 2 days.

Source: https://moatmap.ai/stock/TGTX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker